Does EMAPALUMAB-LZSG Cause Condition aggravated? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Condition aggravated have been filed in association with EMAPALUMAB-LZSG. This represents 12.1% of all adverse event reports for EMAPALUMAB-LZSG.
16
Reports of Condition aggravated with EMAPALUMAB-LZSG
12.1%
of all EMAPALUMAB-LZSG reports
9
Deaths
8
Hospitalizations
How Dangerous Is Condition aggravated From EMAPALUMAB-LZSG?
Of the 16 reports, 9 (56.3%) resulted in death, 8 (50.0%) required hospitalization, and 4 (25.0%) were considered life-threatening.
Is Condition aggravated Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EMAPALUMAB-LZSG. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does EMAPALUMAB-LZSG Cause?
Off label use (51)
Septic shock (19)
Haemophagocytic lymphohistiocytosis (17)
Death (13)
Drug ineffective (11)
Pyrexia (8)
Gastrointestinal haemorrhage (7)
Respiratory failure (6)
Seizure (6)
Colitis (5)
What Other Drugs Cause Condition aggravated?
TOFACITINIB (16,925)
INFLIXIMAB (16,616)
DUPILUMAB (16,459)
ETANERCEPT (15,897)
METHOTREXATE (14,938)
ADALIMUMAB (13,527)
PREDNISONE (10,751)
INFLIXIMAB-DYYB (10,275)
HYDROXYCHLOROQUINE (8,848)
RITUXIMAB (8,627)
Which EMAPALUMAB-LZSG Alternatives Have Lower Condition aggravated Risk?
EMAPALUMAB-LZSG vs EMEND
EMAPALUMAB-LZSG vs EMICIZUMAB
EMAPALUMAB-LZSG vs EMICIZUMAB-KXWH
EMAPALUMAB-LZSG vs EMPAGLIFLOZIN
EMAPALUMAB-LZSG vs EMPAGLIFLOZIN\LINAGLIPTIN